Navigation Links
The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Date:8/19/2007

and we are excited to be moving our clinical program forward. We are very pleased that the MMRC sponsorship has made the rapid initiation of our Phase 2 trials possible and has enabled us to reach out to a larger group of myeloma patients. The thoughtful scientific expertise and collaborative effort of this group have helped speed development of new agents in the field of multiple myeloma," said Lori A. Kunkel, M.D., Chief Medical Officer of Proteolix, Inc.

About the Multiple Myeloma Research Consortium (MMRC)

The Multiple Myeloma Research Consortium (MMRC) is a 509(a)3 non-profit organization that integrates leading academic institutions to accelerate drug development in multiple myeloma. It is led from MMRC offices in Norwalk, Conn., and comprises 13 Member Institutions: City of Hope, Dana-Farber Cancer Institute, Emory University's Winship Cancer Institute, the Cancer Center at Hackensack University Medical Center, H. Lee Moffitt Cancer Center & Research Institute, Mayo Clinic, Ohio State University, Roswell Park Cancer Institute, Saint Vincent's Comprehensive Cancer Center of Saint Vincent Catholic Medical Centers of New York, University Health Network (Princess Margaret Hospital), University of Chicago, University of Michigan, and Washington University. In addition to these trials with Proteolix, the MMRC is supporting six other clinical trials exploring several investigative agents.

The MMRC was founded in 2004 by Kathy Giusti, a myeloma patient, and with the help of the scientific community. The MMRC is a sister organization to the Multiple Myeloma Research Foundation (MMRF), the world's leading funder of multiple myeloma research. The MMRC is widely recognized as an optimal research model to rapidly address critical challenges in drug development and to explore opportunities in the today's most promising research areas- genomics, compound validation, and clinical trials. The MMRC is the only consortium to join academic institutions through
'/>"/>

SOURCE Proteolix

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
2. Velcade (Bortezomib) for Injection Based Therapies Produced Complete Remission Rates as High as 54 Percent in Patients With Previously Treated Multiple Myeloma
3. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
4. Gentiums Defibrotide Seen as Active in Multiple Myeloma
5. ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
6. New Data from Multiple Studies Show Galvus Delivers Consistent and Robust Blood Sugar Control in Patients with Type 2 Diabetes
7. CytRx Announces Clinical Results from Its Rising Multiple Dose Trial with Arimoclomol for ALS
8. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
9. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
10. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
11. Orchestra Therapeutics Announces New Phase II Clinical Data on NeuroVax Demonstrating Marked Expansion of Regulatory T Cell Populations in Patients With Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... DIEGO and WALTHAM, Mass., July 29, 2015 ... is investigating whether certain officers and ... their fiduciary duties to shareholders.  AMAG Pharmaceuticals operates ... maternal health, anemia, and cancer supportive care.  The ... reduce the risk of preterm birth in women ...
(Date:7/29/2015)... Heska Corporation (NASDAQ: HSKA - News; ... diagnostic and other specialty veterinary products , today reported financial ... Second Quarter 2015 Highlights with Prior Year Comparison: ... $1.829 million, from $917 thousand. , Blood Analyzer and ... , Core Companion Animal revenue was up 19% to ...
(Date:7/29/2015)... 2015 The Judicial Panel on Multidistrict Litigation ... to centralize Inferior vena cava (IVC) Filter lawsuits filed ... Medical, have already been centralized by the JPML. ... at risk for a pulmonary embolism. The filters are ... lungs. Claims against Bard and Cook involve incidents of ...
Breaking Medicine Technology:Robbins Arroyo LLP Is Investigating the Officers and Directors of AMAG Pharmaceuticals, Inc. (AMAG) on Behalf of Shareholders 2Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8IVC filter litigation continues; law firm provides free information to IVC filter patients 2
(Date:7/29/2015)... New Port Richey, FL (PRWEB) , ... July ... ... across the nation have become increasingly aware of the impact drinking and substance ... morale, and increased illness. Financial loss is tagged in the billions per year. ...
(Date:7/29/2015)... ... , ... " Core Organizer ” was featured on NewsWatch as part of ... the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and ... help anyone get organized. , Wouldn’t it be great if everyone could be a ...
(Date:7/29/2015)... ... 29, 2015 , ... More than 28,000 students in Pennsylvania ... living with autism will converge upon Penn State to share the latest updates ... Autism Conference will be held Aug. 3-6 at the Penn Stater Conference Center ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to The Spirits Business ... is directly responsible for stimulating and perpetuating alcohol use disorders. Humans have the same ... of the National academy of Sciences, and has given researchers inklings to explore Rsu1 ...
(Date:7/29/2015)... ... 29, 2015 , ... With a new community program in ... Cancer Support Services and announced a new charity campaign to raise funds to ... groups, workshops and educational programs at no charge. Scott Campbell Agency initiates ...
Breaking Medicine News(10 mins):Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3Health News:Get More Organized with the Core Organizer App 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3
... Statement of Michael Bender, Plaintiff, WASHINGTON, June 5 ... Administration has finally agreed to comply with the law,and ... substance that poses a,health risk to pregnant women and ... this week, our lawsuit, Moms,Against Mercury et al. v. ...
... four-week and seventeen-week periods ended May 29,2008., ... Periods ended May 29, 2008 ... Month Year to Date (Dollars in millions) ... weeks), Total retail drug store sales ...
... Medical Corp.,(Nasdaq Capital Market: ESMC) announced today that ... Scientific, Inc. ("Drew") acquired JAS,Diagnostics, Inc. ("JAS"). JAS ... in vitro diagnostics ("IVD") reagents that markets its ... the,world. JAS, based in Miami, Florida, generates annual ...
... Health Magazine, SEATTLE, June 5 Kagome, one ... Mango Orchard natural 100 percent juice,blend have been named ... With the help of top health experts, Health ... fitness to the ultimate test,and unveiled a total of ...
... a lower cost tool than MRI for evaluating new ... News) -- Researchers say they can cheaply and easily ... off a tumor,s blood supply by using the same ... a technique called bioluminescence imaging (BLI), the University of ...
... Massachusetts School of,Professional Psychology, WEST ROXBURY, Mass., ... about the ,invisible wounds of war, - the ... and post traumatic,stress disorder (PTSD) - which raise ... suicide. We need to begin focusing on their,recuperation ...
Cached Medicine News:Health News:US FDA Admits Risks of Mercury Dental Fillings, Settles Lawsuit 2Health News:Longs Reports Preliminary May Retail Drug Store Sales 2Health News:Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics 2Health News:Escalon(R) Enhances Position Within IVD Reagent Market with Strategic Acquisition of JAS Diagnostics 3Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 2Health News:Kagome's Yellow Mango Orchard Blended Juice Named One of America's Healthiest Buys 3Health News:Tracking Cancer Drug's Effectiveness 2Health News:Growing Public Health Crisis of Domestic Violence and Suicides by Returning Veterans 2
Anti-Tg and Anti-TPO are two major autoantibodies implicated in autoimmune related thyroiditis and aid in the differential diagnosis of Hashimoto's thyroiditis and Graves' disease....
... is an automated, turbidimetric, whole- blood assay ... the ability of activated platelets to bind ... of the VerifyNow IIb/IIIa assay device contains ... this analysis. Within the well is an ...
... The Company's first commercial product is ... with single-use, disposable assay devices . The ... products are direct use of a vacuum-type ... a result in minutes. VerifyNow IIb/IIIa, the ...
... ComboMap system provides both pressure and ... singly or in a combined screen ... SmartWire and Volcano's unique Doppler FloWire. ... valuable tools to assess ambiguous or ...
Medicine Products: